公司資料
Talis Biomedical Corp 股價、新聞與催化劑
- 股票代碼:
- TLIS
- 交易所:
- NASDAQ
- 產業:
- MedTech
- 所在地:
- United States
股價為何變動
Current closing-price context is not available for TLIS.
公司概覽
業務概覽
Talis Biomedical was a diagnostics company focused on rapid molecular testing and point-of-care infectious disease detection before becoming a historical ticker. Its business was built around bringing lab-quality testing closer to the patient.
所在地與產業分類
Talis Biomedical was headquartered in the United States and listed on NASDAQ. It sat in diagnostics and medical devices rather than biotechnology therapeutics.
商業模式特徵
The company depended on product commercialization, regulatory progress, and test adoption in clinical settings. Investors historically watched rollout timing, reimbursement, and manufacturing execution.
生技產業定位
Talis was a diagnostics and point-of-care testing name, not a biotech therapeutics developer. It now belongs to the historical diagnostics category.
未來催化劑
- Talis Biomedical is now a legacy / closeout story, so the catalysts are any final strategic or asset-resolution update. The market no longer treats it as a live growth name.
近期新聞
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。